OVIT (OncoVista Innovative Therapies) Book Value per Share: $-0.28 (As of Sep. 2015)


What is OncoVista Innovative Therapies Book Value per Share?

OncoVista Innovative Therapies OVIT Book Value per Share is $-0.28 as of Sep. 2015.

OncoVista Innovative Therapies's book value per share for the quarter that ended in Sep. 2015 was $-0.28.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

OncoVista Innovative Therapies's current price is $0.0001. Its book value per share for the quarter that ended in Sep. 2015 was $-0.28. Hence, today's PB Ratio of OncoVista Innovative Therapies is .

OncoVista Innovative Therapies  (OTCPK:OVIT) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

OncoVista Innovative Therapies Book Value per Share Related Terms

OncoVista Innovative Therapies Book Value per Share Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Book Value per Share Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 -0.01 -0.08 -0.14 -0.26

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.26 -0.27 -0.32 -0.28

OVIT vs RSPI, HSTC, CAPS: Book Value per Share Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's PB Ratio distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's PB Ratio falls into.


OncoVista Innovative Therapies Book Value per Share Calculation

OncoVista Innovative Therapies's Book Value Per Share for the fiscal year that ended in Dec. 2014 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-5.66-0.00)/22.01
=-0.26

OncoVista Innovative Therapies's Book Value Per Share for the quarter that ended in Sep. 2015 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-6.59-0.00)/23.56
=-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $-0.28 mean?
OncoVista Innovative Therapies (OVIT) has a Book Value per Share of $-0.28 as of Sep. 2015. Book value per share gives the per-share value of a company's stockholder equity. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Book Value per Share too high?
OncoVista Innovative Therapies' current Book Value per Share is $-0.28.
How does OncoVista Innovative Therapies' Book Value per Share compare to RSPI and HSTC?
OncoVista Innovative Therapies' Book Value per Share of $-0.28 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Book Value per Share is $-0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Book Value per Share of $-0.28. The current Book Value per Share is $-0.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Book Value per Share is $-0.28 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.